(Q41609736)

5 October 2017

Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo (English)

1 reference

5 October 2017

Suzuki H

1

1 reference

5 October 2017

Yasukawa K

2

1 reference

5 October 2017

Saito T

3

1 reference

5 October 2017

Goitsuka R

4

1 reference

5 October 2017

Hasegawa A

5

1 reference

5 October 2017

Ohsugi Y

6

1 reference

5 October 2017

Taga T

7

1 reference

5 October 2017

Kishimoto T

8

1 reference

5 October 2017

language of work or name

English

0 references

publication date

1 August 1992

1 reference

European Journal of Immunology

5 October 2017

1 reference

5 October 2017

22

1 reference

5 October 2017

1989-1993

1 reference

5 October 2017

8

1 reference

Biological and clinical aspects of interleukin 6.

5 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220806

7 January 2021

Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220806

7 January 2021

Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220806

7 January 2021

AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220806

7 January 2021

Interleukin 6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role in hypergammaglobulinemia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220806

7 January 2021

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220806

7 January 2021

Anti-murine IL-6 receptor antibody inhibits IL-6 effects in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220806

7 January 2021

Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220806

7 January 2021

A severe combined immunodeficiency mutation in the mouse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220806

7 January 2021

A model of human acute lymphoblastic leukemia in immune-deficient SCID mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220806

7 January 2021

Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220806

7 January 2021

Molecular cloning and expression of an IL-6 signal transducer, gp130

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220806

7 January 2021

Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220806

7 January 2021

Growth autonomy and tumorigenicity of interleukin 6-dependent B cells transfected with interleukin 6 cDNA.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220806

7 January 2021

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220806

7 January 2021

Purification and characterization of soluble human IL-6 receptor expressed in CHO cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220806

7 January 2021

High-level expression of human BSF-2/IL-6 cDNA in Escherichia coli using a new type of expression-preparation system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220806

7 January 2021

Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220806

7 January 2021

Identifiers

DOI

10.1002/EJI.1830220806

1 reference

5 October 2017

1 reference